(Q63807725)
Statements
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of JNJ-42756493 (Erdafitinib) in Patients With Tumors Harboring FGFR1/2/3/4 Alterations (English)
0 references
6 November 2017
0 references
31 December 2024
0 references
49
0 references
12 month
0 references
21 year
0 references